Mycobacterium avium complex infection

Also known as: Mycobacterium Avium Complex (MAC) / MAC / Mycobacterium Avium Complex / Mycobacterium avium-intracellulare Infection / Mycobacterium avium intracellulare infection / Infection mycobacterium avium / Mycobacterium avium intracellulare / Battey disease (disorder) / Infection caused by Mycobacterium intracellulare (disorder) / Complement C9 / Active C5b6789 (substance) / Terminal complement complex SC5b-9, vitronectin complexed with C5b-9 (substance) / Complement Membrane Attack Complex / Mycobacterium, MAIS group / Mycobacterium, avium-intracellulare group (organism) / Mycobacterium test / Mycobacteria test

DrugDrug NameDrug Description
DB00479AmikacinAn aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria.
DB00330EthambutolAn antituberculosis agent used in the prophylaxis and treatment of tuberculosis (TB).
DB00615RifabutinAn antibiotic used to treat mycobacterium avium complex disease in patients with HIV.
DB01082StreptomycinAn aminoglycoside antibiotic indicated to treat multi-drug resistant mycobacterium tuberculosis and various non-tuberculosis infections.
DrugDrug NamePhaseStatusCount
DB04835Maraviroc1Completed1
DB00615Rifabutin1Completed1
DB00207Azithromycin2Recruiting1
DB00845Clofazimine2Recruiting1
DB00904Ondansetron2Withdrawn1
DB00207Azithromycin2 / 3Recruiting1
DB00330Ethambutol2 / 3Recruiting1
DB01045Rifampicin2 / 3Recruiting1
DB00207Azithromycin3Recruiting1
DB01211Clarithromycin3Recruiting1
DB00330Ethambutol3Recruiting1
DB01045Rifampicin3Recruiting1
DB00207Azithromycin4Completed1
DB01211Clarithromycin4Completed1
DB00615Rifabutin4Completed1
DB01045Rifampicin4Completed1